Linked Life Data

16145309

Source:http://linkedlifedata.com/resource/pubmed/id/16145309

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2005-9-23
pubmed:abstractText
The lack of a beneficial long-term cardiovascular effect of hormone therapy and the early incidence of cardiovascular adverse events observed in recent randomized studies have been related to a heightened inflammatory effect of hormone therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein, http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptive Agents, Female, http://linkedlifedata.com/resource/pubmed/chemical/Cyproterone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Dydrogesterone, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor Modulators, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP), http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Norethindrone, http://linkedlifedata.com/resource/pubmed/chemical/Norpregnenes, http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene, http://linkedlifedata.com/resource/pubmed/chemical/Thrombomodulin, http://linkedlifedata.com/resource/pubmed/chemical/norethindrone acetate, http://linkedlifedata.com/resource/pubmed/chemical/tibolone
pubmed:status
MEDLINE
pubmed:issn
1072-3714
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
552-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16145309-Age Factors, pubmed-meshheading:16145309-Androgen Antagonists, pubmed-meshheading:16145309-Biological Markers, pubmed-meshheading:16145309-Brachial Artery, pubmed-meshheading:16145309-C-Reactive Protein, pubmed-meshheading:16145309-Cell Adhesion Molecules, pubmed-meshheading:16145309-Contraceptive Agents, Female, pubmed-meshheading:16145309-Cyproterone Acetate, pubmed-meshheading:16145309-Dydrogesterone, pubmed-meshheading:16145309-Estradiol, pubmed-meshheading:16145309-Estrogen Receptor Modulators, pubmed-meshheading:16145309-Estrogens, pubmed-meshheading:16145309-Estrogens, Conjugated (USP), pubmed-meshheading:16145309-Female, pubmed-meshheading:16145309-Hormone Replacement Therapy, pubmed-meshheading:16145309-Humans, pubmed-meshheading:16145309-Interleukin-6, pubmed-meshheading:16145309-Medroxyprogesterone Acetate, pubmed-meshheading:16145309-Middle Aged, pubmed-meshheading:16145309-Multivariate Analysis, pubmed-meshheading:16145309-Norethindrone, pubmed-meshheading:16145309-Norpregnenes, pubmed-meshheading:16145309-Postmenopause, pubmed-meshheading:16145309-Prospective Studies, pubmed-meshheading:16145309-Raloxifene, pubmed-meshheading:16145309-Thrombomodulin
pubmed:articleTitle
Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
pubmed:affiliation
Cardiovascular Research Unit Department of Medical Sciences, Fondazione San Raffaele IRCCS-Roma, Tosinvest Sanita, Roma, Italy.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't